home.aspx

 
.

FROM MG TO KG: FIRST STEPS TOWARDS A SCALABLE PROCESS FOR DRUG SUBSTANCES

SHARESHARESHARE
In this webinar, Anders Högdin, Senior Sales Director at Recipharm discusses the common challenges companies encounter during upscaling. He also outlines the key considerations during the medicinal and process chemistry planning phases, the regulatory requirements and the steps companies can take to streamline the process.